Refresh

Solvay Pharma India Ltd.[Amalgamated] - Research Center

532447 DUPHARPH Group (N.A.) BSE data
Back to Company

Results

Statement

More

Balance Sheet
(Rs crore)
Dec ' 10 Dec ' 09 Dec ' 08 Dec ' 07 Dec ' 06
Sources of funds
Owner's fund

Equity share capital

5.05 5.05 5.05 5.05 5.05

Share application money

- - - - -

Preference share capital

- - - - -

Reserves & surplus

160.88 125.04 104.22 81.75 77.01
Loan funds

Secured loans

- - - - 0.04

Unsecured loans

- - - - -

Total

165.93 130.09 109.27 86.80 82.10
Uses of funds
Fixed assets

Gross block

62.43 64.23 27.83 8.20 10.24

Less : revaluation reserve

- - - - -

Less : accumulated depreciation

26.77 26.69 25.37 3.79 3.15

Net block

35.66 37.54 2.46 4.41 7.09

Capital work-in-progress

- - 35.15 0.06 0.10

Investments

36.67 15.93 16.66 39.84 14.02
Net current assets

Current assets, loans & advances

148.75 118.25 102.89 74.45 86.69

Less : current liabilities & provisions

55.15 41.63 47.90 31.96 25.80

Total net current assets

93.60 76.62 54.99 42.49 60.89

Miscellaneous expenses not written

- - - - -

Total

165.93 130.09 109.27 86.80 82.10
Notes:

Book value of unquoted investments

36.67 15.93 16.66 39.84 14.02

Market value of quoted investments

- - - - -

Contingent liabilities

5.57 3.48 5.15 2.38 0.12

Number of equity sharesoutstanding (Lacs)

50.50 50.50 50.50 50.50 50.50
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com